Simonetta Galgani

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Minimal association between Th1-specific responses to COVID-19 vaccines and SARS-CoV-2 breakthrough infections in multiple sclerosis patients receiving disease-modifying therapies.

Minimal association between Th1-specific responses to COVID-19 vaccines and SARS-CoV-2 breakthrough infections in multiple sclerosis patients receiving disease-modifying therapies.

Journal: Frontiers in immunology

Published: August 08, 2025

Characterization of QuantiFERON-TB-Plus Results in Patients with Tuberculosis Infection and Multiple Sclerosis.

Characterization of QuantiFERON-TB-Plus Results in Patients with Tuberculosis Infection and Multiple Sclerosis.

Journal: Neurology international

Published: June 24, 2025

Multiple sclerosis from onset to secondary progression: a 30-year Italian register study.

Multiple sclerosis from onset to secondary progression: a 30-year Italian register study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: February 02, 2025

Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination.

Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination.

Journal: Vaccines

Published: July 08, 2024

Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose.

Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose.

Journal: International journal of molecular sciences

Published: April 20, 2023

Relapse-associated worsening in a real-life multiple sclerosis cohort: the role of age and pyramidal phenotype.

Relapse-associated worsening in a real-life multiple sclerosis cohort: the role of age and pyramidal phenotype.

Journal: European journal of neurology

Published: December 01, 2022

Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies.

Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: August 19, 2022

Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis.

Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis.

Journal: Neurology

Published: March 13, 2022

Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies.

Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies.

Journal: Journal of neurology

Published: November 18, 2021

Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies.

Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies.

Journal: Journal of neurology

Published: August 06, 2021

Scoring the 10-year risk of ambulatory disability in multiple sclerosis: the RoAD score.

Scoring the 10-year risk of ambulatory disability in multiple sclerosis: the RoAD score.

Journal: European journal of neurology

Published: January 08, 2021

Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register.

Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: December 21, 2020

Showing 1-12 of 31

Last Updated: 09/26/2026